Male Birth Control & The Pill: Contraception in Our New Era

Contraceptive Pill

Poised as the first FDA (Food and Drug Administration panel) approved male contraceptive since the condom, Vasalgel (a non-hormonal male contraception) may hit the US market between 2018 to 2020. This will ultimately change the way we view contraception.

Vasalgel is essentially a polymer that’s injected under local anesthetic into the man’s sperm-carrying tubes, accessible through the scrotum and works by blocking sperm and is expected to be reversible through a second injection that dissolves the polymer. The principle is similar to a vasectomy except with this procedure, the effects may be reversible. If the man wishes to restore flow of sperm, the polymer is flushed out of the vas with another injection.


There are other options however which would require men to take a pill: Gendarussa is another non-hormonal contraceptive pill that has gone through phase II human trials in Indonesia. The method is hypothesized to work by preventing the sperm’s ability to fertilise an egg. Another male pill that is being developed by Eppin Pharma Inc, works by targeting Eppin – a protein covering the sperm’s surface – binding it to prevent the sperm from swimming towards the egg.


There are a few contraceptive research projects fostered through crowdfunding. Research has indicated that over 50% of males are willing and interested in taking the pill if available according to Telegraph Wonder Women campaign.

Telegraph Wonder Women is campaigning to raise awareness around taking hormonal contraception and helping women to carefully consider their options.

What are your thoughts? Do you think that male birth control pills present a positive potential change in relationships, sex and reproductive health?

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>